Related Experiment Video
Updated: Feb 14, 2026

Measuring Neuromuscular Junction Functionality
Published on: August 6, 2017
Neuromuscular features of hypophosphatasia
1Centre de recherche cerveau et cognition (CERCO), université de Toulouse UPS; CNRS CERCO UMR 5549, pavillon Baudot, CHU Purpan, BP 25202, 31052 Toulouse Cedex 03, France.
Insights
The neuromuscular symptoms of hypophosphatasia (HPP) are not well understood. Research suggests the enzyme Alkaline Phosphatase (ALPL) may play a role in neurological and muscle issues seen in HPP patients.
Area of Science:
- Biochemistry
- Neurology
- Genetics
Background:
- The exact causes of neuromuscular issues in hypophosphatasia (HPP) are unknown.
- Severe HPP in infants presents with pyridoxine-sensitive seizures, while hypotonia and muscle weakness affect all age groups.
- Chronic pain is a common symptom with an unclear mechanism.
Purpose of the Study:
- To explore the underlying pathophysiology of neuromuscular manifestations in hypophosphatasia.
- To investigate the role of Alkaline Phosphatase (ALPL) in HPP-related neurological and muscular symptoms.
Main Methods:
- Review of existing literature on HPP pathophysiology.
- Analysis of the expression and function of ALPL in neuronal and muscle cells.
- Examination of potential metabolic pathways involving ALPL, vitamin B6, and neurotransmitters.
Main Results:
- ALPL is expressed in brain and muscle cells, suggesting a direct role in these tissues.
- ALPL knockout impacts neuronal function in animal models.
- Metabolic disruptions involving GABA and vitamin B6 metabolism are implicated.
Conclusions:
- Understanding the neuromuscular pathophysiology of HPP is crucial.
- Further research is needed to assess the potential of new therapies targeting ALPL or related pathways.
Abstract:
The pathophysiology of the neuromuscular manifestations of hypophosphatasia (HPP) remains unknown. Pyridoxine-sensitive seizures characterize severe forms of infantile HPP. Young children and infants affected with severe forms of HPP, but also adults often present with myopathy characterized by hypotonia or muscle weakness. Chronic pain, of unclear mechanism is also often present. Tissue-non-specific alkaline phosphatase (Alkaline Phosphatase-Liver/Bone/Kidney [ALPL]) is expressed in brain neuronal cell and in muscle cells during development and adulthood. The knockout of the ALPL impacts neuronal functions in animal models. This may occur through metabolic anomalies involving gamma-aminobutyric acid (GABA) and other neurotransmitters via the metabolism of pyridoxal phosphate (vitamin B6) and phosphoethanolamine. In this context, a greater understanding of the neuromuscular pathophysiology of HPP is critical to assess the potential impact of new therapies.
Related Concept Videos
The Neuromuscular Junction
Toxidromes: Clinical Features
Neuromuscular Junction And Blockade
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Special Features of Adaptive Immunity
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
Esophageal Strictures-II: Clinical Features and Management
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...

